Works matching AU Fumio Imamura


Results: 76
    1
    2
    3
    4
    5

    Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity.

    Published in:
    Clinical Lung Cancer, 2013, v. 14, n. 5, p. 502, doi. 10.1016/j.cllc.2013.03.003
    By:
    • Takayuki Takimoto;
    • Takashi Kijima;
    • Yasushi Otani;
    • Shinpei Nonen;
    • Yoshinobu Namba;
    • Masahide Mori;
    • Soichiro Yokota;
    • Seigo Minami;
    • Kiyoshi Komuta;
    • Junji Uchida;
    • Fumio Imamura;
    • Mitsugi Furukawa;
    • Naotoshi Tsuruta;
    • Yasushi Fujio;
    • Junichi Azuma;
    • Isao Tachibana;
    • Atsushi Kumanogoh
    Publication type:
    Article
    6
    7
    8

    Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.

    Published in:
    Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 327, doi. 10.3892/mco.2017.1340
    By:
    • YUKI AKAZAWA;
    • MASAHIKO HIGASHIYAMA;
    • KAZUMI NISHINO;
    • JYUNJI UCHIDA;
    • TORU KUMAGAI;
    • TAKAKO INOUE;
    • AYAKO FUJIWARA;
    • TOSHITERU TOKUNAGA;
    • JIRO OKAMI;
    • FUMIO IMAMURA;
    • KEN KODAMA;
    • HISAYUKI KOBAYASHI
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection.

    Published in:
    PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024143
    By:
    • Miyagi, Yohei;
    • Higashiyama, Masahiko;
    • Gochi, Akira;
    • Akaike, Makoto;
    • Ishikawa, Takashi;
    • Miura, Takeshi;
    • Saruki, Nobuhiro;
    • Bando, Etsuro;
    • Kimura, Hideki;
    • Imamura, Fumio;
    • Moriyama, Masatoshi;
    • Ikeda, Ichiro;
    • Chiba, Akihiko;
    • Oshita, Fumihiro;
    • Imaizumi, Akira;
    • Yamamoto, Hiroshi;
    • Miyano, Hiroshi;
    • Horimoto, Katsuhisa;
    • Tochikubo, Osamu;
    • Mitsushima, Toru
    Publication type:
    Article
    19
    20
    21
    22
    23

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    24
    25
    26

    High‐throughput screening in colorectal cancer tissue‐originated spheroids.

    Published in:
    Cancer Science, 2019, v. 110, n. 1, p. 345, doi. 10.1111/cas.13843
    By:
    • Kondo, Jumpei;
    • Ekawa, Tomoya;
    • Endo, Hiroko;
    • Yamazaki, Kanami;
    • Tanaka, Norio;
    • Kukita, Yoji;
    • Okuyama, Hiroaki;
    • Okami, Jiro;
    • Imamura, Fumio;
    • Ohue, Masayuki;
    • Kato, Kikuya;
    • Nomura, Taisei;
    • Kohara, Arihiro;
    • Mori, Seiichi;
    • Dan, Shingo;
    • Inoue, Masahiro
    Publication type:
    Article
    27
    28
    29

    Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).

    Published in:
    2017
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Hattori, Yoshihiro;
    • Tanaka, Kosuke;
    • Fujita, Shiro;
    • Kotani, Yoshikazu;
    • Nishimura, Takashi;
    • Imamura, Fumio;
    • Yokota, Soichiro;
    • Satouchi, Miyako;
    • Monden, Kazuya;
    • Otsuka, Kojiro;
    • Nishiyama, Akihiro;
    • Tsubouchi, Kazuya;
    • Kaneda, Toshihiko;
    • Yoshioka, Hiroshige;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36

    Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
    By:
    • Sugawara, Shunichi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Nokihara, Hiroshi;
    • Ohe, Yuichiro;
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Goto, Koichi;
    • Maemondo, Makoto;
    • Ichinose, Yukito;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Gemma, Akihiko;
    • Imamura, Fumio;
    • Shingyoji, Masato;
    • Saka, Hideo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Okamoto, Isamu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    37
    38
    39
    40
    41

    Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 13, p. 4501, doi. 10.1002/cam4.3089
    By:
    • Kunimasa, Kei;
    • Hirotsu, Yosuke;
    • Amemiya, Kenji;
    • Nagakubo, Yuki;
    • Goto, Taichiro;
    • Miyashita, Yoshihiro;
    • Kakizaki, Yumiko;
    • Tsutsui, Toshiharu;
    • Otake, Sotaro;
    • Kobayashi, Hiroaki;
    • Higuchi, Rumi;
    • Inomata, Kie;
    • Kumagai, Takashi;
    • Mochizuki, Hitoshi;
    • Nakamura, Harumi;
    • Nakatsuka, Shin‐ichi;
    • Nishino, Kazumi;
    • Imamura, Fumio;
    • Kumagai, Toru;
    • Oyama, Toshio
    Publication type:
    Article
    42
    43

    Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

    Published in:
    BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-3
    By:
    • Minami, Seigo;
    • Kijima, Takashi;
    • Shiroyama, Takayuki;
    • Okafuji, Kohei;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Imamura, Fumio;
    • Osaki, Tadashi;
    • Nakatani, Takeshi;
    • Ogata, Yoshitaka;
    • Yamamoto, Suguru;
    • Namba, Yoshinobu;
    • Otsuka, Tomoyuki;
    • Tachibana, Isao;
    • Komuta, Kiyoshi;
    • Kawase, Ichiro
    Publication type:
    Article
    44
    45
    46

    Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
    By:
    • Katsuyuki Kiura;
    • Fumio Imamura;
    • Hiroshi Kagamu;
    • Shingo Matsumoto;
    • Toyoaki Hida;
    • Kazuhiko Nakagawa;
    • Miyako Satouchi;
    • Isamu Okamoto;
    • Mitsuhiro Takenoyama;
    • Yasuhito Fujisaka;
    • Takayasu Kurata;
    • Masayuki Ito;
    • Kota Tokushige;
    • Hatano, Ben;
    • Makoto Nishio
    Publication type:
    Article
    47
    48
    49

    Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
    By:
    • Kunimasa, Kei;
    • Sugimoto, Naotoshi;
    • Kawamura, Takahisa;
    • Yamasaki, Tomoyuki;
    • Honma, Keiichiro;
    • Nagata, Shigenori;
    • Kukita, Yoji;
    • Fujisawa, Fumie;
    • Inoue, Tazuko;
    • Yamaguchi, Yuko;
    • Kitasaka, Mitsuko;
    • Wakamatsu, Toru;
    • Yamai, Takuo;
    • Yamamoto, Sachiko;
    • Hayashi, Takuji;
    • Inoue, Takako;
    • Tamiya, Motohiro;
    • Imamura, Fumio;
    • Nishimura, Kazuo;
    • Nishino, Kazumi
    Publication type:
    Article
    50